Health Care & Life Sciences » Pharmaceuticals | Mezzion Pharma Co. Ltd.

Mezzion Pharma Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
54,443
68,462
93,165
89,056
62,939
Total Accounts Receivable
2,980
2,561
2,033
2,462
2,091
Inventories
455
2,268
2,051
2,406
2,737
Other Current Assets
798
1,045
926
285
3,081
Total Current Assets
58,675
74,336
98,175
94,210
70,848
Net Property, Plant & Equipment
142
315
749
203
861
Total Investments and Advances
3,181
120
2,150
28
29
Long-Term Note Receivable
-
263
293
332
487
Intangible Assets
1,084
3,027
2,532
307
1,635
Other Assets
348
38
-
835
525
Total Assets
64,041
78,783
107,534
98,085
75,035
ST Debt & Current Portion LT Debt
-
-
-
-
8,175
Accounts Payable
1
5
2,242
3,444
2,469
Income Tax Payable
311
681
239
203
390
Other Current Liabilities
136
10,697
11,478
13,020
9,626
Total Current Liabilities
447
11,384
13,959
16,667
20,660
Long-Term Debt
-
-
25,236
26,255
-
Provision for Risks & Charges
-
-
392
-
-
Deferred Taxes
221
456
754
183
556
Other Liabilities
1,026
1,021
1,021
-
-
Total Liabilities
1,864
12,632
44,997
45,276
21,865
Common Equity (Total)
62,177
66,151
62,537
52,809
53,169
Total Shareholders' Equity
62,177
66,151
62,537
52,809
53,169
Total Equity
62,177
66,151
62,537
52,809
53,169
Liabilities & Shareholders' Equity
64,041
78,783
107,534
98,085
75,035

About Mezzion Pharma Co.

View Profile
Address
3th Floor, C&H Building
Seoul SL 06167
Korea, Republic Of
Employees -
Website http://www.mezzion.co.kr
Updated 09/14/2018
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.